drugset / Trial / NCT03870256
Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to evaluate the effect of oral tranexamic acid plus, sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH) after vaginal delivery
Timeline
- Start
- 2019-04-01
- Primary completion
- 2021-08-01
- Completion
- 2021-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carbetocin | Peptide | 100 ug | Intravenous |
| Comparator | Misoprostol | Other / unclassified | 600 ug | Other |
| Comparator | Tranexamic Acid | Small molecule | 1 g | Oral |
Indications
No indication recorded.